Grace Therapeutics, Inc.
GRCE
$3.21
$0.103.12%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 20.01M | 22.13M | 11.06M | 15.17M | 19.41M |
Total Receivables | 20.00K | 126.00K | 301.00K | 415.00K | 398.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 500.00K | 453.00K | 583.00K | 477.00K | 622.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 20.53M | 22.71M | 11.94M | 16.06M | 20.43M |
|
|||||
Total Current Assets | 20.53M | 22.71M | 11.94M | 16.06M | 20.43M |
Net Property, Plant & Equipment | 14.00K | 2.00K | 19.00K | 21.00K | 23.00K |
Long-term Investments | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
Goodwill | 8.14M | 8.14M | 8.14M | 8.14M | 8.14M |
Total Other Intangibles | 41.13M | 41.14M | 41.13M | 41.13M | 41.13M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | 69.81M | 71.99M | 61.22M | 65.35M | 69.72M |
|
|||||
Total Accounts Payable | 1.34M | 601.00K | 665.00K | 1.68M | 1.55M |
Total Accrued Expenses | 976.00K | 1.33M | 1.31M | 999.00K | 1.05M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 2.32M | 1.93M | 1.97M | 2.67M | 2.60M |
|
|||||
Total Current Liabilities | 2.32M | 1.93M | 1.97M | 2.67M | 2.60M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 3.94M | 3.45M | 7.11M | 6.54M | 7.75M |
Total Liabilities | 6.26M | 5.38M | 9.09M | 9.22M | 10.35M |
|
|||||
Common Stock & APIC | 293.64M | 293.34M | 279.50M | 279.34M | 279.14M |
Retained Earnings | -224.05M | -220.69M | -221.32M | -217.17M | -213.74M |
Treasury Stock & Other | -6.04M | -6.04M | -6.04M | -6.04M | -6.04M |
Total Common Equity | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 63.55M | 66.61M | 52.14M | 56.13M | 59.36M |
|